BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35811443)

  • 1. Loss of SLC46A1 decreases tumor iron content in hepatocellular carcinoma.
    Wang D; Wu H; Yang J; Li M; Ling C; Gao Z; Lu H; Shen H; Tang Y
    Hepatol Commun; 2022 Oct; 6(10):2914-2924. PubMed ID: 35811443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC46A1 contributes to hepatic iron metabolism by importing heme in hepatocytes.
    Li H; Wang D; Wu H; Shen H; Lv D; Zhang Y; Lu H; Yang J; Tang Y; Li M
    Metabolism; 2020 Sep; 110():154306. PubMed ID: 32621820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron homeostasis and its disruption in mouse lung in iron deficiency and overload.
    Giorgi G; D'Anna MC; Roque ME
    Exp Physiol; 2015 Oct; 100(10):1199-216. PubMed ID: 26047483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load.
    Fillebeen C; Charlebois E; Wagner J; Katsarou A; Mui J; Vali H; Garcia-Santos D; Ponka P; Presley J; Pantopoulos K
    Blood; 2019 Jan; 133(4):344-355. PubMed ID: 30538134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.
    Adachi M; Kai K; Yamaji K; Ide T; Noshiro H; Kawaguchi A; Aishima S
    Histopathology; 2019 Jul; 75(1):63-73. PubMed ID: 30811632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and regulation of intestinal iron absorption.
    Morgan EH; Oates PS
    Blood Cells Mol Dis; 2002; 29(3):384-99. PubMed ID: 12547229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?
    Rausa M; Pagani A; Nai A; Campanella A; Gilberti ME; Apostoli P; Camaschella C; Silvestri L
    PLoS One; 2015; 10(4):e0122696. PubMed ID: 25860887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in iron status and hepcidin expression in rats.
    Kong WN; Niu QM; Ge L; Zhang N; Yan SF; Chen WB; Chang YZ; Zhao SE
    Biol Trace Elem Res; 2014 Aug; 160(2):258-67. PubMed ID: 24962641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications.
    Tseng HH; Chang JG; Hwang YH; Yeh KT; Chen YL; Yu HS
    J Cancer Res Clin Oncol; 2009 Oct; 135(10):1413-20. PubMed ID: 19387685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin directly inhibits transferrin receptor 1 expression in astrocytes via a cyclic AMP-protein kinase A pathway.
    Du F; Qian C; Qian ZM; Wu XM; Xie H; Yung WH; Ke Y
    Glia; 2011 Jun; 59(6):936-45. PubMed ID: 21438013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat.
    Pascale RM; De Miglio MR; Muroni MR; Simile MM; Daino L; Seddaiu MA; Pusceddu S; Gaspa L; Calvisi D; Manenti G; Feo F
    Hepatology; 1998 Feb; 27(2):452-61. PubMed ID: 9462644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical study of placental syncytiotrophoblasts in neonatal hemochromatosis.
    Shimono A; Imoto Y; Sakamoto H; Chiba Y; Matsumoto K; Kawauchi M; Kusaka T; Tanaka H; Hata T; Kushida Y; Ueno M
    Placenta; 2016 Dec; 48():49-55. PubMed ID: 27871472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin in hepatocellular carcinoma.
    Joachim JH; Mehta KJ
    Br J Cancer; 2022 Jul; 127(2):185-192. PubMed ID: 35264787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron Metabolism in the Peripheral Nervous System: The Role of DMT1, Ferritin, and Transferrin Receptor in Schwann Cell Maturation and Myelination.
    Santiago González DA; Cheli VT; Wan R; Paez PM
    J Neurosci; 2019 Dec; 39(50):9940-9953. PubMed ID: 31676601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norcantharidin down-regulates iron contents in the liver and spleen of lipopolysaccharide-treated mice.
    Zheng J; Wang JJ; Ma HM; Shen MQ; Qian ZM; Bao YX
    Redox Rep; 2022 Dec; 27(1):119-127. PubMed ID: 35735222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma.
    Babu KR; Muckenthaler MU
    Sci Rep; 2019 Feb; 9(1):1518. PubMed ID: 30728365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma.
    Li M; Tang Y; Wang D; Zhai X; Shen H; Zhong C; Yao M; Jin A; Zhou Z; Zhou S; Fan J; Ling CQ; Ling C
    Mol Ther; 2022 Feb; 30(2):703-713. PubMed ID: 34547466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of iron metabolism-related genes in diethylnitrosamine-induced mouse liver tumors.
    Youn P; Kim S; Ahn JH; Kim Y; Park JD; Ryu DY
    Toxicol Lett; 2009 Feb; 184(3):151-8. PubMed ID: 19061943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal protein restriction depresses the duodenal expression of iron transporters and serum iron level in male weaning piglets.
    Ma W; Lu J; Jiang S; Cai D; Pan S; Jia Y; Zhao R
    Br J Nutr; 2017 Apr; 117(7):923-929. PubMed ID: 28534724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepcidin and DNA promoter methylation in hepatocellular carcinoma.
    Udali S; Castagna A; Corbella M; Ruzzenente A; Moruzzi S; Mazzi F; Campagnaro T; De Santis D; Franceschi A; Pattini P; Gottardo R; Olivieri O; Perbellini L; Guglielmi A; Choi SW; Girelli D; Friso S
    Eur J Clin Invest; 2018 Feb; 48(2):e12870. PubMed ID: 29235098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.